AnhydrohirundigeninCAS# 20853-99-0 |
| Cas No. | 20853-99-0 | SDF | File under preparation. |
| PubChem ID | 102060418.0 | Appearance | Powder |
| Formula | C21H28O4 | M.Wt | 344.4 |
| Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (1R,4R,5R,8S,16S,19S,22R)-5,19-dimethyl-15,18,20-trioxahexacyclo[14.5.1.01,14.04,13.05,10.019,22]docosa-10,13-dien-8-ol | ||
| SMILES | CC12CCC(CC1=CCC3=C4C5(CCC23)COC6(C5C(O4)CO6)C)O | ||
| Standard InChIKey | VSXJBZJIZDSPFF-JGQRDLFRSA-N | ||
| Standard InChI | InChI=1S/C21H28O4/c1-19-7-5-13(22)9-12(19)3-4-14-15(19)6-8-21-11-24-20(2)17(21)16(10-23-20)25-18(14)21/h3,13,15-17,22H,4-11H2,1-2H3/t13-,15-,16+,17+,19-,20+,21-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Anhydrohirundigenin Dilution Calculator
Anhydrohirundigenin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.9036 mL | 14.518 mL | 29.036 mL | 58.072 mL | 72.59 mL |
| 5 mM | 0.5807 mL | 2.9036 mL | 5.8072 mL | 11.6144 mL | 14.518 mL |
| 10 mM | 0.2904 mL | 1.4518 mL | 2.9036 mL | 5.8072 mL | 7.259 mL |
| 50 mM | 0.0581 mL | 0.2904 mL | 0.5807 mL | 1.1614 mL | 1.4518 mL |
| 100 mM | 0.029 mL | 0.1452 mL | 0.2904 mL | 0.5807 mL | 0.7259 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
- 9 (10) -Z-α-trans-Bergamotenol
Catalog No.:BCX2881
CAS No.:88034-74-6
- L-γ-Glutamyl-S-(1E)-1-propen1-yl-L-cysteine
Catalog No.:BCX2880
CAS No.:134677-41-1
- Quercetin 3-O-β-D-(6’’-O-malonyl)galactopyranoside
Catalog No.:BCX2879
CAS No.:84392-08-5
- Azukisaponin II
Catalog No.:BCX2878
CAS No.:82793-03-1
- Citrinin
Catalog No.:BCX2877
CAS No.:518-75-2
- Cascaroside C
Catalog No.:BCX2876
CAS No.:53823-09-9
- Cascaroside D
Catalog No.:BCX2875
CAS No.:53861-35-1
- Calendulaglycoside C
Catalog No.:BCX2874
CAS No.:26020-29-1
- Phanginin A
Catalog No.:BCX2873
CAS No.:1011528-58-7
- 3-(1-Carboxyvinyloxy)benzoic acid
Catalog No.:BCX2872
CAS No.:16929-37-6
- Esculentoside S
Catalog No.:BCX2871
CAS No.:156031-83-3
- Jasnudifloside B
Catalog No.:BCX2870
CAS No.:244230-40-8
- Luteolin-7-O-β-D-apiofuranosyl-(1→6)-β-D-glucopyransodie
Catalog No.:BCX2883
CAS No.:211561-67-0
- Caesaljapin
Catalog No.:BCX2884
CAS No.:144161-80-8
- Prunasinamide
Catalog No.:BCX2885
CAS No.:151649-54-6
- Propinquain H
Catalog No.:BCX2886
CAS No.:1426059-47-3
- Heterophyllin A
Catalog No.:BCX2887
CAS No.:145459-18-3
- (25R)-12α-Hydroxyspirost-4-en-3-one
Catalog No.:BCX2888
CAS No.:50888-50-1
- Angulasaponin B
Catalog No.:BCX2889
CAS No.:1628031-59-3
- Kadsutherin G
Catalog No.:BCX2890
CAS No.:2692637-23-1
- Kadsutherin F
Catalog No.:BCX2891
CAS No.:2692637-03-7
- Hirundigoside E
Catalog No.:BCX2892
CAS No.:2192292-95-6
- Tenuifoliose S
Catalog No.:BCX2893
CAS No.:1456888-64-4
- Interiorin B
Catalog No.:BCX2894
CAS No.:133442-66-7
Three new steroidal glycosides from the roots of Cynanchum stauntonii.[Pubmed:23555098]
Biomed Res Int. 2013;2013:816145.
Three new steroidal glycosides, named as stauntosides L, M, and N (1-3), along with one known C21 steroidal glycoside, Anhydrohirundigenin monothevetoside (4), were isolated from the 95% ethanol extract of the roots of Cynanchum stauntonii. The structures of these new compounds were elucidated on the basis of extensive spectroscopic analyses, mainly 1D and 2D NMR, HRESI-MS, and chemical methods.
Steroids from the roots of Cynanchum stauntonii.[Pubmed:15549665]
Planta Med. 2004 Nov;70(11):1075-9.
A chemical investigation of the roots of Cynanchum stauntonii has resulted in the characterization of a new hydroperoxide with a 13,14 : 14,15-disecopregnane-type skeleton, named stauntonine (1), together with three related compounds, Anhydrohirundigenin (2), Anhydrohirundigenin monothevetoside (3), and glaucogenin-C mono- D-thevetoside (4). Their structures were established by spectroscopic methods, including X-ray crystallographic diffraction analysis of stauntonine that confirmed its relative stereochemistry. The compound 1 showed dose-dependent relaxation on aortic rings with endothelium contracted by phenylepherine or KCl.
[C21 steroidal constituents from Cynanchum hancockianum].[Pubmed:1481676]
Yao Xue Xue Bao. 1992;27(8):595-602.
Two new compounds hancogenin B (V) and hancoside A (VI) and four known compounds glucogenin C (I), cynatratoside A (II), glaucogenin A (III) and Anhydrohirundigenin (IV) were isolated from the roots of Cynanchum hancockianum (Maxim) Al. Iljinski. Their structures were identified on the basis of spectral evidence. The fragmentation ways of 13:14, 14:15-secopregnenes in EIMS were outlined and the antitumor activity of II and the antiendotoxic activity of VI were also preliminarily tested in vitro.
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
